Vernalis plc Company Profile (LON:VER)

About Vernalis plc (LON:VER)

Vernalis plc logoVernalis plc is a commercial-stage pharmaceutical company. The Company is engaged in the research, development and commercialization of pharmaceutical products. The Company operates through two segments: Commercial, which covers all areas relating to the commercial sale of pharmaceutical products, the manufacture and distribution directly related to that activity, and Research and Development, which includes all activities related to the research and development of pharmaceutical products for a range of medical disorders. The Company markets three products, including Tuzistra XR in the United States prescription cough cold market; Moxatag, which is a once daily amoxicillin approved in the United States for tonsillitis and pharyngitis, and frovatriptan, which is an acute treatment for migraine. The Company also has four over prescription cough cold products under development and a pipeline of new chemical entity (NCE) development programs and research collaborations.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:VER
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: £95.4 million
  • Outstanding Shares: 526,351,000
Average Prices:
  • 50 Day Moving Avg: GBX 20.99
  • 200 Day Moving Avg: GBX 28.59
  • 52 Week Range: GBX 16 - GBX 49.75
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £11.87 million
  • Price / Sales: 8.04
  • Book Value: GBX 0.18 per share
  • Price / Book: 1.03
Profitability:
  • EBIDTA: ($28,070,000.00)
Misc:
  • Average Volume: 452,628 shs.
 

Frequently Asked Questions for Vernalis plc (LON:VER)

What is Vernalis plc's stock symbol?

Vernalis plc trades on the London Stock Exchange (LON) under the ticker symbol "VER."

Where is Vernalis plc's stock going? Where will Vernalis plc's stock price be in 2017?

5 brokers have issued 12 month price objectives for Vernalis plc's stock. Their predictions range from GBX 24 to GBX 88. On average, they anticipate Vernalis plc's share price to reach GBX 46.80 in the next year. View Analyst Ratings for Vernalis plc.

Who are some of Vernalis plc's key competitors?

How do I buy Vernalis plc stock?

Shares of Vernalis plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Vernalis plc stock cost?

One share of Vernalis plc stock can currently be purchased for approximately GBX 18.13.

Analyst Ratings

Consensus Ratings for Vernalis plc (LON:VER) (?)
Ratings Breakdown: 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: GBX 46.80

Analysts' Ratings History for Vernalis plc (LON:VER)
Show:
DateFirmActionRatingPrice TargetDetails
4/21/2017N+1 SingerReiterated RatingHoldGBX 28View Rating Details
4/21/2017Stifel NicolausLower Price TargetHoldGBX 29 -> GBX 24View Rating Details
4/21/2017Numis Securities LtdReiterated RatingAddGBX 29View Rating Details
4/21/2017Panmure GordonDowngradeHoldGBX 65View Rating Details
2/14/2017Canaccord GenuityReiterated RatingBuyGBX 88View Rating Details
12/21/2016Shore CapitalReiterated Ratinghouse stockView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for Vernalis plc (LON:VER)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Vernalis plc (LON:VER)
Current Year EPS Consensus Estimate: $-5.570 EPS

Dividends

Dividend History for Vernalis plc (LON:VER)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Vernalis plc (LON:VER)
Insider Trades by Quarter for Vernalis plc (LON:VER)
Insider Trades by Quarter for Vernalis plc (LON:VER)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/12/2016David MackneyInsiderSell27,233GBX 39£10,620.87
9/30/2016Carol FergusonInsiderBuy28,000GBX 41£11,480
6/9/2016Mackney,DavidInsiderBuy97,000GBX 45£43,650
5/5/2015Nigel SheailInsiderBuy84,000GBX 59.90£50,316
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Vernalis plc (LON:VER)
Latest Headlines for Vernalis plc (LON:VER)
Source:
DateHeadline
americanbankingnews.com logoVernalis plc (VER) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - May 22 at 12:25 PM
finance.yahoo.com logoServier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration - Yahoo Finance
finance.yahoo.com - April 26 at 8:24 AM
americanbankingnews.com logoVernalis plc (VER) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - April 25 at 12:32 PM
americanbankingnews.com logoVernalis plc (VER) Downgraded to Hold at Panmure Gordon
www.americanbankingnews.com - April 21 at 9:48 PM
americanbankingnews.com logoVernalis plc (VER) Price Target Cut to GBX 24
www.americanbankingnews.com - April 21 at 9:48 PM
americanbankingnews.com logoNumis Securities Ltd Reiterates "Add" Rating for Vernalis plc (VER)
www.americanbankingnews.com - April 21 at 9:48 PM
finance.yahoo.com logoVernalis PLC: FDA Issues a Complete Response Letter on CCP-07 NDA
finance.yahoo.com - April 21 at 9:22 AM
americanbankingnews.com logoStifel Nicolaus Lowers Vernalis plc (VER) Price Target to GBX 29
www.americanbankingnews.com - April 8 at 6:47 PM
americanbankingnews.com logoVernalis plc (VER) Coverage Initiated at Numis Securities Ltd
www.americanbankingnews.com - April 4 at 1:16 PM
americanbankingnews.com logoVernalis plc (VER) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 31 at 1:14 PM
americanbankingnews.com logoN+1 Singer Lowers Vernalis plc (VER) Price Target to GBX 28
www.americanbankingnews.com - March 25 at 8:55 PM
morningstar.co.uk logoVernalis Partners With Servier On Oncology Drug-Discovery
www.morningstar.co.uk - March 6 at 11:47 AM
reuters.com logoBRIEF-Vernalis Plc enters drug discovery collaboration with Servier
www.reuters.com - March 6 at 11:47 AM
reuters.com logoUK Stocks-Factors to watch on Feb. 21
www.reuters.com - February 21 at 4:23 PM
finance.yahoo.com logoVernalis PLC: Unaudited Interim Results for the six months ended 31 December 2016
finance.yahoo.com - February 21 at 4:23 PM
biz.yahoo.com logoHalf Year 2017 Vernalis PLC Earnings Release - Time Not Supplied
biz.yahoo.com - February 21 at 4:23 PM
uk.finance.yahoo.com logoIs this small-cap value stock the next Shire plc?
uk.finance.yahoo.com - February 21 at 4:23 PM
finance.yahoo.com logoVernalis achieves a $3 million milestone payment from Corvus Pharmaceuticals Inc
finance.yahoo.com - February 14 at 6:56 AM
finance.yahoo.com logoVernalis PLC: Notice of Results for Six Months Ended 31/12/2016
finance.yahoo.com - January 30 at 10:10 AM
finance.yahoo.com logoVernalis PLC: FDA accepts CCP-08 NDA for full review
finance.yahoo.com - December 21 at 5:25 AM
finance.yahoo.com logoVernalis plc: AGM Statement
finance.yahoo.com - December 1 at 8:51 PM
finance.yahoo.com logoVernalis Begins Promotion Of MOXATAG® (Amoxicillin Extended-Release) Tablets To Primary Care Physicians In The US
finance.yahoo.com - October 11 at 7:43 PM

Social

Social activity is not available for this stock.

Chart

Vernalis plc (VER) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff